Teri Walters v. Donald S Falik

CourtMichigan Court of Appeals
DecidedJanuary 29, 2015
Docket319016
StatusUnpublished

This text of Teri Walters v. Donald S Falik (Teri Walters v. Donald S Falik) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Teri Walters v. Donald S Falik, (Mich. Ct. App. 2015).

Opinion

STATE OF MICHIGAN

COURT OF APPEALS

TERI WALTERS and KIM WALTERS, UNPUBLISHED January 29, 2015 Plaintiffs-Appellants,

v No. 319016 Eaton Circuit Court DONALD S. FALIK, D.D.S., d/b/a FALIK LC No. 12-000658-NH FAMILY DENTISTRY, ROBERT C. FALIK, D.D.S., and JANE DOE,

Defendants-Appellees.

Before: MURPHY, P.J., and METER and SERVITTO, JJ.

METER, J. (dissenting).

Because I believe that the lower court properly exercised its discretion in excluding the testimony of Dr. M. Eric Gershwin, I respectfully dissent. I would affirm the trial court’s ruling.

Plaintiffs contended that defendants erroneously provided phosphoric acid etching solution to Teri Walters instead of the teeth-whitening solution that they were supposed to have provided. In February 2011, Teri used this solution overnight. Defendant Donald Falik agreed that etching solution is only intended to be used for seconds at a time. Teri testified at her deposition that in the morning after she used the solution, it felt like her mouth was burning. She claimed that defendants admitted giving her the wrong solution and that they attempted to repair the stains that had resulted on her teeth.

In April 2011, Teri was diagnosed with chronic sinusitis and later complained of a plugging sensation in her left ear. After persistent symptoms, she was diagnosed with Wegener’s granulomatosis (WG), an autoimmune disease that shortens typical lifespan and that is characterized by symptoms such as inflammation of the sinuses and lungs. Plaintiffs’ proposed expert witness, Gershwin, testified during his deposition that, in his opinion, Teri developed WG because of the use of the etching solution combined with a genetic predisposition to WG.

Gershwin testified that WG occurs in persons who are genetically predisposed to having a “promiscuous” immune system that is highly responsive to antibodies. He stated that some mechanism will induce the death of cells, causing the release of a “neutrophillic antigen,” and a person who is genetically susceptible will then mount an immune response. He testified that there are a variety of environmental agents that can contribute to the response. Gershwin admitted that he had provided no literature concluding that phosphoric acid causes or contributes -1- to WG, but stated that there are data about solvents, hydrocarbons, and silica, which is adjacent to phosphorus on the periodic table. Gershwin testified that what happened was that the phosphoric acid hit water, dissociated, and produced a large inflammatory response. He opined that although plaintiff might have gotten WG at some point regardless, she would not have gotten it when she did without the exposure to the etching solution.

Defendants filed a motion in limine to exclude Gershwin’s testimony due to lack of supporting evidence that exposure to phosphoric acid is recognized as a cause of WG. The trial court heard argument on the motion on September 19, 2013, and issued its decision from the bench.

Applying MRE 702, the court found that Gershwin was highly qualified in the field and that expert testimony would assist the trier of fact, but went on to find that it was questionable whether his opinion was based on sufficient facts. The court found that the majority of the articles presented by the parties indicated that the etiology for WG was unknown, and none of the studies referred to phosphoric acid or any kind of acid exposure as a cause. The court noted that the literature did not support Gershwin’s conclusions with the same degree of certainty that he professed. The court stated that “the cutting edge of medicine is simply not the standard for a courtroom. In applying MRE 702, I just don’t find his testimony reliable enough to allow it to go to the jury. So I’m going to grant the motion.”

Plaintiffs’ counsel questioned the court regarding the possibility of a Daubert1 hearing. The court stated that it would not preclude a hearing, but it was doubtful whether plaintiffs would be able to prevail. The court specifically stated that there was sufficient time for such a hearing to take place and even stated that it would make accommodations to allow for Gershwin to testify by video. Plaintiffs did not pursue a hearing.

Plaintiffs now contend that the trial court erred in granting defendants’ motion in limine. This Court reviews for abuse of discretion a trial court’s decision whether to admit evidence. Chapin v A & L Parts, Inc, 274 Mich App 122, 126; 732 NW2d 578 (2007).

MRE 702 provides:

If the court determines that scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training, or education may testify thereto in the form of an opinion or otherwise if (1) the testimony is based on sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case.

MCL 600.2955 provides:

1 Daubert v Merrell Dow Pharmaceuticals, Inc, 509 US 579; 113 S Ct 2786; 125 L Ed 2d 469 (1993).

-2- (1) In an action for the death of a person or for injury to a person or property, a scientific opinion rendered by an otherwise qualified expert is not admissible unless the court determines that the opinion is reliable and will assist the trier of fact. In making that determination, the court shall examine the opinion and the basis for the opinion, which basis includes the facts, technique, methodology, and reasoning relied on by the expert, and shall consider all of the following factors:

(a) Whether the opinion and its basis have been subjected to scientific testing and replication.

(b) Whether the opinion and its basis have been subjected to peer review publication.

(c) The existence and maintenance of generally accepted standards governing the application and interpretation of a methodology or technique and whether the opinion and its basis are consistent with those standards.

(d) The known or potential error rate of the opinion and its basis.

(e) The degree to which the opinion and its basis are generally accepted within the relevant expert community. As used in this subdivision, “relevant expert community” means individuals who are knowledgeable in the field of study and are gainfully employed applying that knowledge on the free market.

(f) Whether the basis for the opinion is reliable and whether experts in that field would rely on the same basis to reach the type of opinion being proffered.

(g) Whether the opinion or methodology is relied upon by experts outside of the context of litigation.

(2) A novel methodology or form of scientific evidence may be admitted into evidence only if its proponent establishes that it has achieved general scientific acceptance among impartial and disinterested experts in the field.

(3) In an action alleging medical malpractice, the provisions of this section are in addition to, and do not otherwise affect, the criteria for expert testimony provided in section 2169.

In Chapin, 274 Mich App at 133, the Court recognized the reliance of the expert witness on the “Sir Bradford Hill” methodology for determining causation.

The Sir Bradford Hill methodology, as explained by Dr. Lemen, contains nine criteria, all of which should be considered when determining causation. “Strength of association” means a sufficiently strong association between a substance and an effect can permit conclusions without statistical epidemiologic data. For example, no epidemiological studies were needed to show that cyanide

-3- gas kills film-recovery plant workers when they are exposed to it. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Edry v. Adelman
786 N.W.2d 567 (Michigan Supreme Court, 2010)
Chapin v. a & L PARTS, INC.
732 N.W.2d 578 (Michigan Court of Appeals, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Teri Walters v. Donald S Falik, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teri-walters-v-donald-s-falik-michctapp-2015.